Europe – A Mature Market with Strong Regulatory Backing

добавлена новая статья Health

2026-03-20 10:46:15 -

Europe represents the second-largest market in the Asthma and COPD Drugs Market , valued at USD 10.5 billion in 2024 and holding a 29.70% global share. The region’s growth is driven by a robust healthcare infrastructure, high disease awareness, and supportive regulatory frameworks that encourage innovation and ensure patient access to advanced therapies. Unlike the fragmented...

0 Комментарии 0 Поделились 49 Просмотры 0 предпросмотр